Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06991946
What this trial is testing

Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain

Who this might be right for
Metastatic Breast Cancer
SOLTI Breast Cancer Research Group 300
Not applicableUnknownNCT01050413
What this trial is testing

Evaluation of Thymidine Kinase Activity in the Serum of Patients With Solid Tumors

Who this might be right for
Solid Tumors
Hadassah Medical Organization 300
Large-scale testing (Phase 3)Study completedNCT01850524
What this trial is testing

IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 705
Testing effectiveness (Phase 2)WithdrawnNCT02252978
What this trial is testing

Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences
Not applicableStudy completedNCT04394325
What this trial is testing

Digi-Do - a Digital Information Tool to Help Patients Diagnosed With Breast Cancer

Who this might be right for
Breast Cancer
Jonkoping University 80
Testing effectiveness (Phase 2)Study completedNCT00750815
What this trial is testing

Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 58
Not applicableLooking for participantsNCT07241182
What this trial is testing

Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy

Who this might be right for
Lung Cancer (Diagnosis)
Tri-Service General Hospital (TSGH) 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07735819
What this trial is testing

Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma

Who this might be right for
Low Grade GliomaGlioblastoma
Barbara Ann Karmanos Cancer Institute 61
Not applicableStudy completedNCT01928836
What this trial is testing

Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China

Who this might be right for
Lung Neoplasms
Bai Chunxue 764
Testing effectiveness (Phase 2)Study completedNCT03566199
What this trial is testing

MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma

Who this might be right for
Diffuse Intrinsic Pontine Glioma
Sabine Mueller, MD, PhD 7
Testing effectiveness (Phase 2)Looking for participantsNCT05254327
What this trial is testing

Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001

Who this might be right for
Rectal Cancer
University of Nebraska 118
Testing effectiveness (Phase 2)Looking for participantsNCT05675813
What this trial is testing

Genotype-guided Treatment in Newly Diagnosed PTCL

Who this might be right for
Peripheral T Cell Lymphoma
Ruijin Hospital 264
Not applicableStudy completedNCT01220960
What this trial is testing

Art Therapy Intervention for Breast Cancer Patients

Who this might be right for
Breast Cancer
Dr. Sarkis Meterissian 64
Testing effectiveness (Phase 2)Looking for participantsNCT07107529
What this trial is testing

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

Who this might be right for
Multiple Myeloma (MM)
European Myeloma Network B.V. 150
Large-scale testing (Phase 3)UnknownNCT04446130
What this trial is testing

Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients

Who this might be right for
Induction ChemotherapyAcute T-Lymphocytic LeukemiaT-cell Lymphoblastic Lymphoma Leukemia+1 more
The First Affiliated Hospital of Soochow University 100
Early research (Phase 1)Study completedNCT01020292
What this trial is testing

A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma

Who this might be right for
Glioma
Abramson Cancer Center at Penn Medicine 31
Testing effectiveness (Phase 2)Looking for participantsNCT07537400
What this trial is testing

Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5

Who this might be right for
High-Risk Neuroblastoma
Shaare Zedek Medical Center 10
Not applicableStudy completedNCT02739867
What this trial is testing

Tumor-educated Platelets in Venous Thromboembolism

Who this might be right for
NeoplasmsVenous Thromboembolism
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 476
Not applicableStudy completedNCT06189261
What this trial is testing

Holistic Needs Assessments in Patients With Melanoma

Who this might be right for
MelanomaUnsatisfied Needs
University of Surrey 30
Not applicableEnded earlyNCT04947618
What this trial is testing

Efficacy of Patient Management for Lymphoma Diagnosed at Nimes University Hospital From 1999 to 2018. DVR-Lym-Nim

Who this might be right for
Lymphoma, Malignant
Centre Hospitalier Universitaire de Nīmes 136
Next Page